Stepping up for the Global HAE movement
On the hereditary angioedema (HAE) day, May 16, 2022, and in line with HAE International (HAEi) objectives, we organized a webinar covering updates on the diagnosis, prevention, and management of HAE to raise awareness in the medical community.
At the webinar, barriers to drug availability and proper HAE treatment were also discussed, highlighting the importance of awareness at different levels of the community to achieve more prompt emergency medical care during HAE attacks.
For over 15 years, IAARI has been actively supporting HAE patients through providing care and specialized laboratories and this is with great pleasure to announce that the plasma-derived C1 Esterase Inhibitor, Berinert, will soon be available throughout the country.
comment